A pan-cancer view reveals that TP53 was the most mutated across cancer types, while 18 GATA3 mutations and 6 ATRX mutations were specific to breast cancer (BRCA) and lower-grade glioma (LGG), respectively. This evidence concerns the gene TP53 and glioma.